FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmaceutics, namely to a drug substance and a biologically active substance carrier for treating and diagnosing representing a nanoparticle having a ferric oxide coated zirconium dioxide nucleus having a nearly spherical shape and a size of 15-100 nm, and to a method for preparing the carrier wherein to a solution containing iron II, iron III and zirconium IV cations, having pH=7.5; an ammonium mixture is added to pH=8-9 at a rate providing preparing t nanoparticles of a pre-set size of 15-100 nm; the product is recovered by centrifugation, washed and lyophilised.
EFFECT: invention provides creating the new drug substance and the biologically active substance carrier.
4 cl, 2 ex, 1 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| MULTICOMPONENT NANOSIZED SYSTEM FOR DIAGNOSIS AND THERAPY OF NEW GROWTHS | 2020 |
|
RU2729617C1 |
| METHOD OF PRODUCING HEAT-SENSITIVE NANOPARTICLES BASED ON 2-HYDROXYPROPYL-β-CYCLODEXTRIN | 2014 |
|
RU2578421C1 |
| METHOD OF PRODUCING WATER-SOLUBLE ADDUCTS BASED ON MAGNETICALLY ORDERED IRON OXIDES AND SUBSTITUTED BETA-CYCLODEXTRINS | 2009 |
|
RU2453499C2 |
| STAND FOR RESEARCH OF PROCESS OF MAGNETOCONTROLLABLE NANOPARTICLE DELIVERY INTO VASCULAR SYSTEM (VERSIONS) | 2015 |
|
RU2619854C2 |
| WATER-COMPATIBLE POLYMER COMPOSITIONS FOR DELIVERY OF BIOLOGICALLY ACTIVE SUBSTANCES | 2015 |
|
RU2580649C1 |
| HYDROCARBON CONVERSION CATALYSTS AND A METHOD FOR PREPARATION THEREOF | 2005 |
|
RU2276621C1 |
| INTRINSICALLY MAGNETIC HYDROXYAPATITE | 2011 |
|
RU2575566C2 |
| METHOD OF DELIVERING WATER-INSOLUBLE AND POORLY SOLUBLE BIOACTIVE SUBSTANCES AND PHARMACEUTICAL FORM BASED ON IT | 2006 |
|
RU2325151C2 |
| METHOD OF OBTAINING MAGNETOSENSITIVE LIPOSOMES | 2007 |
|
RU2357724C1 |
| MONODISPERSE COLLOIDAL AQUEOUS SOLUTION OF SILVER IONS WITH ANTIMICROBIAL AND ANTITOXIC ACTION (VERSIONS) AND METHOD OF ITS PRODUCTION | 2015 |
|
RU2609176C2 |
